Acute Intermittent Porphyria Market Size is Projected to Reach USD 7.1 million by 2034, Growth at CAGR 3.9% | Report by Transparency Market Research, Inc.
Implementation of novel treatment protocols enhances patient care and outcomes, driving continuous improvement in Acute Intermittent Porphyria (AIP) management.
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 27, 2024 (GLOBE NEWSWIRE) — The global acute intermittent porphyria market (급성 간헐성 포르피린증 시장) is estimated to surge at a CAGR of 3.9% from 2024 to 2034. Transparency Market Research projects that the overall sales revenue for acute intermittent porphyria is estimated
Acute Intermittent Porphyria Market: Competitive Landscape
The competitive landscape of the acute intermittent porphyria market is evolving rapidly with several pharmaceutical companies investing in research and development. Established players like Recordati Rare Diseases and Alnylam Pharmaceuticals dominate with their innovative therapies addressing AIP symptoms and complications.
Emerging biotech firms such as Axcella Health and Dicerna Pharmaceuticals are advancing novel treatment approaches targeting underlying molecular mechanisms. Collaboration with academic institutions and patient advocacy groups further drives innovation.
As the understanding of AIP pathophysiology deepens, competition intensifies, fostering a dynamic environment aimed at improving patient outcomes and enhancing the quality of life for individuals living with this rare genetic disorder. Some prominent players are as follows:
- Alnylam Pharmaceuticals, Inc.
- Clinuvel Pharmaceuticals Ltd.
- BioMarin Pharmaceutical Inc.
- Recordati
- Quest Diagnostics
- Invitae Corp.
- Laboratory Corporation of America Holdings (Labcorp)
- ARUP Laboratories
Product Portfolio
- Recordati is a leading pharmaceutical company offering a diverse portfolio of innovative medicines and treatments. With a focus on rare diseases and specialty areas, Recordati is committed to improving patient outcomes and enhancing quality of life globally through cutting-edge research and development.
- Quest Diagnostics is a trusted provider of diagnostic testing, information, and services. With a comprehensive portfolio of laboratory and diagnostic solutions, Quest empowers healthcare professionals and patients alike to make informed decisions and achieve better health outcomes through accurate and timely testing.
Acute Intermittent Porphyria Market: Key Segments
By Diagnosis
- Blood Test
- Urine Test
- DNA Test
- Serum Test
By Treatment
- Gonadotropin-Releasing Hormone Analogues
- Prophylactic Hematin Infusions
By End User
- Hospitals
- Clinics
- Research Centers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
More Trending Reports by Transparency Market Research –
Diabetes Devices Market (糖尿病機器市場) – The global diabetes devices market is projected to advance at a CAGR of 6.0% from 2022 to 2031
Vaccines Market (Marché des vaccins) – The global vaccines market is projected to expand at a CAGR of 4.2% during the forecast period from 2023 to 2031
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
Follow Us: LinkedIn| Twitter| Blog | YouTube
